Disclosures for "Self-Management for People with Epilepsy and a History of Negative Health Events (SMART): A Randomized Controlled Effectiveness Trial"
-
Dr. SAJATOVIC has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck, Janssen, Teva, Otsuka, Alkermes. The institution of Dr. SAJATOVIC has received research support from Neurelis, Intra-Cellular, Merck, Otsuka, Alkermes, International Society for Bipolar Disorders (ISBD), National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), . Dr. SAJATOVIC has received publishing royalties from a publication relating to health care.
-
The institution of Dr. Ghearing has received research support from Center for Disease Control and Prevention.
-
Ms. Tyrrell has nothing to disclose.
-
Ms. Black has nothing to disclose.
-
Mrs. Krehel-Montgomery has nothing to disclose.
-
Mr. Barigye has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Privitera has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK life science. Dr. Privitera has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace. Dr. Privitera has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK life science. Dr. Privitera has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Jazz. The institution of Dr. Privitera has received research support from Neurelis. The institution of Dr. Privitera has received research support from Biohaven. Dr. Privitera has received research support from Neurava.
-
Dr. Rossi has nothing to disclose.
-
The institution of Prof. Briggs has received research support from NIH.